Related Experiment Video
Updated: Feb 10, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review
Roger A Barker1, Melissa K Carpenter2, Stuart Forbes3
1Cambridge University, Cambridge Centre for Brain Repair, E.D. Adrian Building, Cambridge CB2 2PY, UK.
Abstract:
Stem cell-based clinical interventions are increasingly advancing through preclinical testing and approaching clinical trials. The complexity and diversity of these approaches, and the confusion created by unproven and untested stem cell-based "therapies," create a growing need for a more comprehensive review of these early-stage human trials to ensure they place the patients at minimal risk of adverse events but are also based on solid evidence of preclinical efficacy with a clear scientific rationale for that effect. To address this issue and supplement the independent review process, especially that of the ethics and institutional review boards who may not be experts in stem cell biology, the International Society for Stem Cell Research (ISSCR) has developed a set of practical questions to cover the major issues for which clear evidence-based answers need to be obtained before approving a stem cell-based trial.
Insights
The International Society for Stem Cell Research (ISSCR) created practical questions to guide the approval of stem cell therapies. This ensures patient safety and evidence-based efficacy for clinical trials.
Area of Science:
- Regenerative Medicine
- Translational Science
- Biomedical Ethics
Background:
- Stem cell interventions are progressing toward clinical trials, necessitating rigorous evaluation.
- Unproven stem cell therapies create confusion and potential patient risk.
- Existing review processes may lack specialized stem cell biology expertise.
Purpose of the Study:
- To address the need for comprehensive review of early-stage stem cell trials.
- To supplement ethics and institutional review boards' assessments.
- To ensure patient safety and scientifically sound stem cell interventions.
Main Methods:
- Development of a set of practical questions by the International Society for Stem Cell Research (ISSCR).
- Focus on evidence-based answers for preclinical efficacy and scientific rationale.
- Guidance for the approval process of stem cell-based trials.
Main Results:
- A structured framework for evaluating stem cell trial applications.
- Identification of key questions for assessing scientific validity and safety.
- Support for informed decision-making by review boards.
Conclusions:
- Standardized questions are crucial for the responsible advancement of stem cell therapies.
- Ensuring preclinical evidence and safety is paramount before human trials.
- ISSCR guidelines aim to foster trust and rigor in stem cell research.
More Related Videos
10:48Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions
Published on: November 26, 2014
09:03Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
Related Concept Videos
Ethics in Research
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical Applications of Epidermal Stem Cells
Statistical Software for Data Analysis and Clinical Trials
Review and Preview
Percentiles are a type of fractile that partition data into...